Sensitivity and responsiveness of Ibadan stroke-specific pain scale by Osundiya, O.C. et al.
M
Sensitivity and Responsiveness of Ibadan Stroke-Specific
Pain Scale
Osundiya O.C.,  Owolabi M.O.,  Hamzat T.K.1 2 2
Physiotherapy Department, University College Hospital, Ibadan1
College of Medicine, University of Ibadan2
Correspondence
Osundiya Oladunni C. PhD, Physiotherapy Department, University College Hospital, Ibadan
(cosundiya@yahoo.com)
SUMMARY 
Sensitivity and responsiveness to change are important psychometric properties of outcome measures,
especially in evaluating therapeutic effectiveness (Dromeric and Redeng, 2003). The consequences of an
outcome measure that lacks responsiveness are the same as a diagnostic test that has poor sensitivity or
specificity (Scrimshaw and Maher, 2001).  The ability of an instrument to be sensitive to within patient
change is very important in clinical trials especially in a disease like stroke where the impact is often life-long
and multi-dimensional (Poissant et al, 2003). 
The purpose of this study therefore was to investigate the responsiveness of the Ibadan Stroke-Specific
Pain Scale (IbSSPS) in evaluating post-stroke pain. 
Fifty-six patients with first-incidence stroke experiencing post-stroke pain were assessed for pain.
Sensitivity to change was assessed by analysing changes in the IbSSPS scores before and after six weeks of
physiotherapy with the Wilcoxon-sign rank test. Standardized effect size (SES) and standardized response
mean (SRM) were used to assess responsiveness.
The overall IbSSPS and its four domains were sensitive to change after 6 weeks of physiotherapy. It was
therefore concluded that the IbSSPS is a sensitive and responsive scale that can be used to evaluate pain in
stroke survivors.
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INTRODUCTION
Recovery and long-term health of stroke survivors can be
adversely affected by a number of medical complications,
including chronic pain (Yang et al, 2009). However,
because of the subjective nature of pain, clinical importance
is not always easy to determine (Farrar et al, 2001). 
Pain which is one of the most common and highly
challenging medical problems in health care is one of the
most frequently observed complications of stroke (Zorowitz
et al, 2005).  Though it is increasingly recognized as a
consequence of stroke (Klit at al, 2011; Miller et al, 2013)
and may be serious enough to jeopardize recovery by
hindering rehabilitation (Jonsson et al, 2006), its assessment
is fundamental in selecting an appropriate therapy and
modifying therapy according to the individual patient’s
response (Zeferino and Aycock, 2010). 
Generic scales often do not tap attributes that are
relevant to stroke patients and exhibit low sensitivity; hence
the need for a stroke-specific measure (Owolabi, 2010).
They are not designed for specific diseases and are thus not
sensitive to subtle patient-specific and disease-specific
changes (Williams et al, 1999 Owolabi, 2010). Generic
measures lack adequate content validity for stroke, they are
not suitable for routine clinical use or clinical trials in
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stroke (Owolabi, 2010) while disease-specific measures
have been found to quantify the impact of a specific pain
problem on function and can be used to track changes after
an intervention (Garrat et al, 2001).
Responsiveness is the ability of a measure to detect a
clinically important and meaningful change while sensitivity
shows a statistically significant change irrespective of the
relevance or meaningfulness of such change (Liang et al,
2002).Using sensitive and responsive measures enhance
clinical practice (van der Putten  et al, 1999).
A newly developed stroke-specific pain scale – the
Ibadan Stroke Specific Pain Scale (IbSSPS), which
combines both self-report and clinician report has no
reports yet on its responsiveness and sensitivity. These are
prerequisites for its utility as an outcome measure (Terwee
et al, 2007) hence, this study evaluated the responsiveness
and sensitivity to change of the IbSSPS.
A Priori Statement
To determine the sensitivity to change of the IbSSPS, it was
hypothesized that it will report statistically significant
differences in IbSSPS scores after a six-week intervention.
A second hypothesis was that the IbSSPS will be sensitive
to change in the pain status of the survivors after 6 weeks
of treatment.
METHODS
This was a prospective study of stroke survivors with not
more than 12 months stroke onset. Participants were
consecutively recruited patients from the outpatient
physiotherapy clinic of the University College Hospital,
who were able to communicate and willing to participate.
Ability to communicate was assessed by three word
commands, e.g. ‘Make a fist’, ‘Touch your nose’.  Patients
with severe cognitive deficits and co-morbidities such as
cancer were excluded from the study. The study was
conducted between May 2012 and January 2013. Of the 64
stroke patients recruited into the study, 8 were lost to
follow-up and were therefore excluded from the study. 
Data Collection
Ethical approval was granted by the University of
Ibadan/University College Hospital, Ethical Committee. 
Data on age, sex, stroke laterality, stroke onset, pain
onset and IbSSPS score were obtained at baseline, while the
IbSSPS was re-administered after 6 weeks of physiotherapy. 
The Ibadan Stroke Specific Pain Scale (IbSSPS)
The IbSSPS is a multidimensional stroke-specific pain scale
which combines a self and clinician’s report. It contains 36
items in 4 domains (Pain location/Severity, Psychosocial
functioning, Physical functioning and Signs and Symptoms).
Items in the first 3 domains are scored on a 5-point Likert
scale. The items in the fourth domain which is a clinician’s
report is scored absent or present. It is evaluative, revealing
the presence or absence of signs and symptoms of different
types of post-stroke pain and hence not summed.  
Patients respond to each item using the corresponding
response set as indicated. Scores in each domain are
summed up while the total IbSSPS score is a summation of
the first 3 domains with a maximum score of 144, with
higher scores indicating higher pain status.  
 
Data Analysis
Data were screened for normality. Non-normality was
addressed using appropriate transformations. Descriptive
statistics of mean, standard deviation, frequencies and
percentages were used to summarize the demographic and
clinical data of the stroke patients.
Sensitivity was determined by examining the changes
in domain and overall IbSSPS scores between the baseline
and after 6 weeks of physiotherapy using the Wilcoxon
signed rank test.
Responsiveness was assessed using the standardized
effect size (SES) and standardized response mean (SRM)
(Kazis et al, 1989). The SES was calculated as mean
difference in IbSSPS scores between the baseline and 6
weeks (Kazis et al, 1989), while the standardized response
mean (SRM) was calculated as the ratio of mean change to
the standard deviation of that change.  
SRM or SES of <0.2 depicts no responsiveness, 0.2 –
0.5 mild responsiveness, 0.5 – 0.71 moderate
responsiveness, while a SRM or SES greater than 0.7
represents marked responsiveness (Cohen, 1977). The level
of statistical significance was set at 0.05.
RESULTS
Fifty-six  out of sixty-four  stroke survivors completed the
study. The majority (68%) had left-sided hemiplegia and
32% had right-sided hemiplegia with a duration of pain
onset between 2 and 16 weeks.
Across the four domains, there was significant
reduction in the IbSSPS scores of the participants after
physiotherapy (table 1), this showing good sensitivity.
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Table 1. Comparison of Ibadan Stroke-Specific Pain Scale scores
before and after 6-weeks of Physiotherapy using the Wilcoxon-
signed rank test (N=56)
Pre Post
Z p X  ±  SD X  ±  SD
Pain
location/severity 6.80 5.21 4.63 3.69 -5.40 <0.001*
Psychosocial
functioning      10.16 6.21 7.87 4.94 -5.22 <0.001*
Physical
functioning 20.79 11.36 17.69 9.92 -3.72 <0.001*
Signs &
symptoms 3.48 1.18 2.32 1.65 -3.94 <0.001*
TOTAL 41.51 18.86 32.41 15.31 -4.98 <0.001*
 Significant at < 0.01
The standardized effect size for the domains ranged
between 0.31 and 0.70 (table 2).  The standardized
response mean also ranged between 0.5 and 0.9.  This
connotes the ability of the IbSSPS to pick clinically relevant
changes in the pain status.
Table 2. Responsiveness of IbSSPS domains after 6 weeks
Physiotherapy using Standardized Effect Size and Standardized
Response Mean
Domain SES SRM
Pain location/severity 0.59 0.90
Psychosocial functioning 0.47 0.8
Physical functioning 0.31 0.5
Signs and Symptoms 0.70 0.6
SES - Standardized Effect Size
SRM - Standardized Response Mean
DISCUSSION
Sensitivity and responsiveness, though components of
validity, have been considered separate attributes of
outcome measures because of their pivotal role in clinical
trials (Terwee et al, 2007). Generic pain measures are
commonly used even in stroke trials despite the
disadvantage that the majority of these measures are
unlikely to address issues that are of great importance to the
stroke survivors or capture the multidimensional nature of
post-stroke pain. One of such measures is the Visual
Analogue Scale (VAS), which is preferred to McGill when
measuring pain in clinical trials and clinical practice
because it is more responsive in assessing pain over a
period of 24 hours (Scrimshaw and Maher, 2001).
This study examined the sensitivity and responsiveness
to change of a stroke-specific pain scale, the IbSSPS.  All
the domains of the IbSSPS had at least mild responsiveness
while the pain location/severity and the psychosocial
functioning exhibited marked responsiveness with
standardized effect size and standardized response mean
(SRM) above 0.70. This is indicative of the extent to which
the scores on the scale reflect changes in the patient’s
condition which is expected to be in line with the direction
of pain status. These changes were related to the subjective
improvement or alteration of pain after 6 weeks of
physiotherapy intervention.
The mild responsiveness observed in the physical
functioning domain is an indication that despite the negative
impact of post-stroke pain on motor functioning, the
relationship between functional disability and pain levels is
not always strong.  Changes in pain level are not always
highly correlated with changes in functional disability and
vice versa (Palermo et al, 2004). This is because pain is not
an independent predictor of function especially in a
disabling and multifaceted disease like stroke. 
The signs and symptoms domain being discriminatory
and not necessarily needing to be responsive to change
(Terwee et al, 2007) still demonstrated moderate
responsiveness.
The IbSSPS demonstrated a good attribute of a disease-
specific measure as it was able to detect small
improvements and deteriorations. This trend is similar to
the one reported by Williams et al (1999) in the
development and validation of a stroke-specific quality of
life scale. This makes it a useful tool that can complete
favourably as a stroke-specific instrument in assessing the
impact of therapeutic and rehabilitative interventions in
stroke patients as it is able to assess meaningful changes.
Although preferential or selective therapeutic effect was
not demonstrated, the observed changes after intervention
were evident for both total and sub-scores.  This is contrary
to the findings of Bouhassira et al (2004) in the validation
of the Neuropathic Pain Scale. They found the Neuropathic
Pain Scale to be responsive to changes but the changes were
only evident for the total score not for the sub-scores.  
The inclusion of participants with mild to moderate
cognitive impairment is an area of strength for the IbSSPS
because using a list of words to describe pain has been
found to be better for patients with cognitive impairment
(Chibnall and Tait, 2001). 
One limitation of this scale, which has been found with
other pain rating scales is the likely loss of data with stroke
survivors with severe cognitive deficit. 
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CONCLUSION
Our results suggest that the IbSSPS is a sensitive and
responsive tool to assess post-stroke pain. Results show  a
significant change in IbSSPS score both for the total and
subscale scores and further support the use of such a scale
for detecting and treating pain in stroke survivors.  This
also confirms the clinical utility of the scale. 
Overall, the IbSSPS is a novel clinical tool for
assessing pain in stroke survivors, and hence would lead to
significant improvement in the care of stroke survivors in
the future.
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